Kristen Kluska
Stock Analyst at Cantor Fitzgerald
(4.82)
# 481
Out of 4,966 analysts
382
Total ratings
49%
Success rate
22.4%
Average return
Main Sectors:
Stocks Rated by Kristen Kluska
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RARE Ultragenyx Pharmaceutical | Reiterated: Buy | $103 → $33 | $14.30 | +130.77% | 18 | Sep 3, 2026 | |
| IRON Disc Medicine | Reiterated: Buy | $125 | $70.06 | +78.42% | 18 | Aug 31, 2026 | |
| SLDB Solid Biosciences | Reiterated: Buy | $16 → $26 | $8.70 | +198.85% | 3 | Aug 26, 2026 | |
| CAPR Capricor Therapeutics | Upgraded: Buy | $3.5 → $28 | $8.37 | +234.53% | 16 | Aug 14, 2026 | |
| RNA Atrium Therapeutics | Reiterated: Buy | $25 | $10.36 | +141.31% | 2 | Aug 13, 2026 | |
| MNPR Monopar Therapeutics | Downgraded: Hold | $109 → $119 | $110.26 | +7.93% | 10 | Aug 12, 2026 | |
| PTCT PTC Therapeutics | Reiterated: Buy | $130 | $66.06 | +96.79% | 25 | Aug 12, 2026 | |
| CDXS Codexis | Reiterated: Buy | $11 | $1.47 | +650.85% | 11 | Aug 11, 2026 | |
| TSX: EPRX Eupraxia Pharmaceuticals Inc. | Reiterated: Buy | $26.33 | $11.69 | +125.26% | 11 | Aug 11, 2026 | |
| TSHA Taysha Gene Therapies | Reiterated: Buy | $19 | $5.02 | +278.49% | 20 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $61 | $36.90 | +65.31% | 27 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $8.19 | +95.36% | 10 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $30 → $12 | $9.23 | +30.01% | 13 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $21 | $20.45 | +2.69% | 28 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 → $25 | $12.01 | +108.16% | 10 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $38 → $43 | $47.24 | -8.98% | 14 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $11.85 | +305.06% | 9 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $63 → $67 | $41.64 | +60.90% | 10 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $4.78 | +130.13% | 5 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | kr 23.00 | kr 7.89 | +191.51% | 1 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $44.51 | - | 12 | Jun 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $0.28 | +971.43% | 10 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $4.28 | +343.93% | 5 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $24 | $3.80 | +531.58% | 8 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 | $2.04 | +684.31% | 9 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $5.42 | +417.08% | 11 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $8.36 | +246.89% | 7 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $3.50 | +300.00% | 8 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $7 | $0.5676 | n/a | 4 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $6.04 | n/a | 6 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.01 | n/a | 3 | Feb 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 → $20 | $0.66 | n/a | 2 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $14.43 | n/a | 3 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $1.40 | n/a | 3 | Jun 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $28.10 | n/a | 1 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.58 | n/a | 2 | Jun 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.5 → $28 | $0.0706 | n/a | 2 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $28 → $20 | $0.000001 | n/a | 3 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 6 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.25 → $10 | $1.21 | n/a | 3 | Dec 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $180 | $4.17 | n/a | 1 | Dec 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 | $1.02 | n/a | 6 | Sep 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.5072 | n/a | 4 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $0.00795 | n/a | 1 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 | $0.4801 | n/a | 1 | Nov 30, 2020 |
Ultragenyx Pharmaceutical
Sep 3, 2026
Reiterated: Buy
Price Target: $103 → $33
Current: $14.30
Upside: +130.77%
Disc Medicine
Aug 31, 2026
Reiterated: Buy
Price Target: $125
Current: $70.06
Upside: +78.42%
Solid Biosciences
Aug 26, 2026
Reiterated: Buy
Price Target: $16 → $26
Current: $8.70
Upside: +198.85%
Capricor Therapeutics
Aug 14, 2026
Upgraded: Buy
Price Target: $3.5 → $28
Current: $8.37
Upside: +234.53%
Atrium Therapeutics
Aug 13, 2026
Reiterated: Buy
Price Target: $25
Current: $10.36
Upside: +141.31%
Monopar Therapeutics
Aug 12, 2026
Downgraded: Hold
Price Target: $109 → $119
Current: $110.26
Upside: +7.93%
PTC Therapeutics
Aug 12, 2026
Reiterated: Buy
Price Target: $130
Current: $66.06
Upside: +96.79%
Codexis
Aug 11, 2026
Reiterated: Buy
Price Target: $11
Current: $1.47
Upside: +650.85%
Eupraxia Pharmaceuticals Inc.
Aug 11, 2026
Reiterated: Buy
Price Target: $26.33
Current: $11.69
Upside: +125.26%
Taysha Gene Therapies
Aug 11, 2026
Reiterated: Buy
Price Target: $19
Current: $5.02
Upside: +278.49%
Aug 6, 2026
Reiterated: Buy
Price Target: $61
Current: $36.90
Upside: +65.31%
Aug 6, 2026
Reiterated: Buy
Price Target: $16
Current: $8.19
Upside: +95.36%
Aug 5, 2026
Reiterated: Hold
Price Target: $30 → $12
Current: $9.23
Upside: +30.01%
Aug 5, 2026
Reiterated: Hold
Price Target: $21
Current: $20.45
Upside: +2.69%
Aug 5, 2026
Reiterated: Buy
Price Target: $34 → $25
Current: $12.01
Upside: +108.16%
Aug 4, 2026
Reiterated: Hold
Price Target: $38 → $43
Current: $47.24
Upside: -8.98%
Jul 16, 2026
Reiterated: Buy
Price Target: $48
Current: $11.85
Upside: +305.06%
Jul 9, 2026
Reiterated: Buy
Price Target: $63 → $67
Current: $41.64
Upside: +60.90%
Jun 25, 2026
Reiterated: Buy
Price Target: $11
Current: $4.78
Upside: +130.13%
Jun 25, 2026
Initiated Coverage: Buy
Price Target: kr 23.00
Current: kr 7.89
Upside: +191.51%
Jun 17, 2026
Upgraded: Buy
Price Target: n/a
Current: $44.51
Upside: -
May 12, 2026
Reiterated: Buy
Price Target: $3
Current: $0.28
Upside: +971.43%
Mar 30, 2026
Reiterated: Buy
Price Target: $19
Current: $4.28
Upside: +343.93%
Mar 19, 2026
Reiterated: Buy
Price Target: $15 → $24
Current: $3.80
Upside: +531.58%
Mar 10, 2026
Reiterated: Hold
Price Target: $16
Current: $2.04
Upside: +684.31%
Feb 23, 2026
Reiterated: Buy
Price Target: $28
Current: $5.42
Upside: +417.08%
Jan 13, 2026
Reiterated: Buy
Price Target: $29
Current: $8.36
Upside: +246.89%
Nov 21, 2025
Reiterated: Buy
Price Target: $14
Current: $3.50
Upside: +300.00%
Jul 1, 2024
Reiterated: Buy
Price Target: $6 → $7
Current: $0.5676
Upside: n/a
May 13, 2024
Rated: Buy
Price Target: n/a
Current: $6.04
Upside: n/a
Feb 4, 2024
Reiterated: Buy
Price Target: $6
Current: $1.01
Upside: n/a
Aug 30, 2023
Downgraded: Hold
Price Target: $4 → $20
Current: $0.66
Upside: n/a
Aug 28, 2023
Reiterated: Buy
Price Target: $23
Current: $14.43
Upside: n/a
Jun 28, 2023
Reiterated: Buy
Price Target: $27
Current: $1.40
Upside: n/a
Jun 26, 2023
Reiterated: Buy
Price Target: $17
Current: $28.10
Upside: n/a
Jun 9, 2023
Rated: Hold
Price Target: n/a
Current: $2.58
Upside: n/a
May 15, 2023
Reiterated: Buy
Price Target: $3.5 → $28
Current: $0.0706
Upside: n/a
Mar 16, 2023
Downgraded: Hold
Price Target: $28 → $20
Current: $0.000001
Upside: n/a
Mar 10, 2023
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Dec 21, 2022
Reiterated: Hold
Price Target: $4.25 → $10
Current: $1.21
Upside: n/a
Dec 29, 2021
Initiated Coverage: Buy
Price Target: $180
Current: $4.17
Upside: n/a
Sep 28, 2021
Reiterated: Hold
Price Target: $4
Current: $1.02
Upside: n/a
May 12, 2021
Reiterated: Buy
Price Target: $10
Current: $0.5072
Upside: n/a
Mar 2, 2021
Initiated Coverage: Buy
Price Target: $22
Current: $0.00795
Upside: n/a
Nov 30, 2020
Initiated Coverage: Buy
Price Target: $9
Current: $0.4801
Upside: n/a